Profund Advisors’s Vor Biopharma VOR Stock Holding History

Profund Advisors’s Portfolio VOR Stock Details VOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$393K	Buy	+22,015	New	+$310K	0.01%	631

Other funds holding VOR

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Profund Advisors's VOR Position: Q1 2026 in Review

Profund Advisors opened a new position in Vor Biopharma (VOR) in Q1 2026: 22,015 shares worth $393K. The stake represents 0.01% of the portfolio and ranks #631 among its holdings.

80 funds tracked by Wall St. Rank hold VOR as of Q1 2026.

Profund Advisors held 22,015 shares of Vor Biopharma worth $393K as of Q1 2026.
Vor Biopharma was a new Profund Advisors position in Q1 2026.
Vor Biopharma made up 0.01% of Profund Advisors's portfolio in Q1 2026, its #631 holding.
80 funds tracked by Wall St. Rank held Vor Biopharma as of Q1 2026.

Based on Profund Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.